Citra Borneo Utama Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Citra Borneo Utama Tbk. trades at Rp795 (market cap 2.47T, 58.6K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Citra Borneo Utama Tbk. is far larger — about 7.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 58.6K). Which is the better fit depends on your goals.
| CBUT | DGNS | |
|---|---|---|
Market Cap | 2.47T | 310.75B |
Volume | 58.6K | 963.6K |
Lot | 586 | 9.64K |
Turnover | 46.6M | 217.67M |
Average Price | 795.15 | 225.89 |
Value | 46.6M | 217.67M |
Indicative Equilibrium Price | 795 | 226 |
Indicative Equilibrium Volume | 1 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →